Additionally, more cell, animal and clinical sample‐based investigations are needed to further explore the potential role or clinical benefits of GAS2L1, GAS2L2 and GAS2L3 in the aetiology and pathogenesis of relevant diseases, such as tumours. This evidence concerns the gene GAS2L3 and neoplasm.